Evidence map›Paper›PMID 30850686›Full record

ArticleScientific reports2019

Fine particulate matter (PM2.5) inhibits ciliogenesis by increasing SPRR3 expression via c-Jun activation in RPE cells and skin keratinocytes.

Ji-Eun Bae, Hyunjung Choi, Dong Woon Shin, Hye-Won Na, Na Yeon Park, Joon Bum Kim, Doo Sin Jo, Min Ji Cho, Jung Ho Lyu, Jeong Ho Chang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review of sensory systems deployed by epidermal keratinocytes.Frontiers in cell and developmental biology · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Short-term exposure of PMFrontiers in public health · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Primary Cilia in the Skin: Functions in Immunity and Therapeutic Potential.Frontiers in cell and developmental biology · 2021
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Ji-Eun BaeSchool of Life Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea.
Hyunjung ChoiR&D Unit, AmorePacific Corporation, Yongin, Gyeonggi-do, 17074, Republic of Korea.
Dong Woon ShinGraduate School of East-West Medical Science, Kyung Hee University, Yongin, Gyeonggi-do, 17104, Republic of Korea.
Hye-Won NaR&D Unit, AmorePacific Corporation, Yongin, Gyeonggi-do, 17074, Republic of Korea.
Na Yeon ParkSchool of Life Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea.
Joon Bum KimSchool of Life Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea.
Doo Sin JoSchool of Life Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea.
Min Ji ChoDepartment of Genetic Engineering, Kyung Hee University, Yongin, Gyeonggi-do, 17104, Republic of Korea.
Jung Ho LyuDepartment of Genetic Engineering, Kyung Hee University, Yongin, Gyeonggi-do, 17104, Republic of Korea.
Jeong Ho ChangDepartment of Biology Education, Kyungpook National University, Daegu, 41566, South Korea.
Eunjoo H LeeGraduate School of East-West Medical Science, Kyung Hee University, Yongin, Gyeonggi-do, 17104, Republic of Korea.
Tae Ryong LeeR&D Unit, AmorePacific Corporation, Yongin, Gyeonggi-do, 17074, Republic of Korea.
Hyoung-June KimR&D Unit, AmorePacific Corporation, Yongin, Gyeonggi-do, 17074, Republic of Korea. leojune@amorepacific.com.
Dong-Hyung ChoSchool of Life Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea. dhcho@knu.ac.kr.
Kyungpook National University · KRAmorepacific (South Korea) · KRKyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to fine particulate matter (PM) with diameter <2.5 µm (PM2.5) causes epithelium injury and endothelial dysfunction. Primary cilia are sensory organelles that transmit extracellular signals into intracellular biochemical responses and have roles in physiology. To date, there have been no studies investigating whether PM2.5 affects primary cilia in skin. We addressed this in the present study using normal human epidermal keratinocytes (NHEKs) and retinal pigment epithelium (RPE) cells. We found that formation of primary cilium is increased in differentiated NHEKs. However, treatment with PM2.5 blocked increased ciliogenesis in NHEKs and RPE cells. Furthermore, PM2.5 transcriptionally upregulated small proline rich protein 3 (SPRR3) expression by activating c-Jun, and ectopic expression of SPRR3 inhibits suppressed the ciliogenesis. Accordingly, treatment with c-Jun activator (anisomycin) induced SPRR3 expression, whereas the inhibitor (SP600125) recovered the ciliated cells and cilium length in PM2.5-treated cells. Moreover, c-Jun inhibitor suppressed upregulation of SPRR3 in PM2.5-treated cells. Taken together, our finding suggested that PM2.5 inhibits ciliogenesis by increasing SPRR3 expression via c-Jun activation in RPE cells and keratinocytes.

Indexed as

Cell DifferentiationCell LineCiliaCornified Envelope Proline-Rich ProteinsHumansKeratinocytesOxidative StressParticulate MatterProto-Oncogene Proteins c-junReactive Oxygen SpeciesRetinal Pigment EpitheliumSkinUp-RegulationCornified Envelope Proline-Rich ProteinsParticulate MatterProto-Oncogene Proteins c-junReactive Oxygen SpeciesSPRR3 protein, human

Identifiers

PMID30850686
PMCPMC6408442
OpenAlexW2920599272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.